rema assay Search Results


rema-exakt  (DENTAURUM GmbH Co KG)
90
DENTAURUM GmbH Co KG rema-exakt
Rema Exakt, supplied by DENTAURUM GmbH Co KG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rema+assay/rema+exakt/pmc04878208-42-33-35
Average 90 stars, based on 1 article reviews
rema-exakt - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
refractory cast rema exact f  (DENTAURUM GmbH Co KG)
90
DENTAURUM GmbH Co KG refractory cast rema exact f
Refractory Cast Rema Exact F, supplied by DENTAURUM GmbH Co KG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rema+assay/refractory+cast+rema+exact+f/pm40249516-51-28-33
Average 90 stars, based on 1 article reviews
refractory cast rema exact f - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
bacterial biofilm activator rema  (Marburg GmbH)
90
Marburg GmbH bacterial biofilm activator rema
Bacterial Biofilm Activator Rema, supplied by Marburg GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rema+assay/bacterial+biofilm+activator+rema/pmc08481266__41467_2021_26005_MOESM1_ESM-3-6-32
Average 90 stars, based on 1 article reviews
bacterial biofilm activator rema - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
rema  (MiddleBrook Pharmaceuticals)
90
MiddleBrook Pharmaceuticals rema
Rema, supplied by MiddleBrook Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rema+assay/rema/pm27076101-95-48-36
Average 90 stars, based on 1 article reviews
rema - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
1×rema buffer  (Biotype Diagnostic GmbH)
90
Biotype Diagnostic GmbH 1×rema buffer
1×Rema Buffer, supplied by Biotype Diagnostic GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rema+assay/1%C3%97rema+buffer/us10669573-13-133-146
Average 90 stars, based on 1 article reviews
1×rema buffer - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
silicone duplicating material  (DENTAURUM GmbH Co KG)
90
DENTAURUM GmbH Co KG silicone duplicating material
Silicone Duplicating Material, supplied by DENTAURUM GmbH Co KG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rema+assay/rema++sil+silicone+duplicating+material/pm26438981-69-8-11
Average 90 stars, based on 1 article reviews
silicone duplicating material - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
resazurin microtitre cell viability assay rema  (Promega)
90
Promega resazurin microtitre cell viability assay rema
Antimicrobial compound hits identified from screening the Pathogen Box against M chimaera A) Validation of the <t>REMA</t> screening approach for M chimaera , demonstrating an estimated Z factor of 0·87. 50 times rifampicin mean MIC (2·5 μg/mL; red diamond) was compared to 2% dimethyl sulfoxide drug-free media (yellow triangle) in the REMA assay. Data points from three independent experiments were pooled. (B) The 400 Pathogen Box compounds screened against M chimaera, M tuberculosis , and M abscessus at 20 μM with cell survival quantified by REMA. Any compound that inhibited growth by 70% or more were classed as a hit (green bar). Compounds have been classified by MMV as A for cryptosporidiosis; B for kinetoplastids; C for malaria; D for reference compounds; E for schistosomiasis; and F for tuberculosis. (C) Venn diagram describing the overlap in antimicrobial compound hits against M chimaera, M abscessus , and M tuberculosis . The compounds are detailed as a drug name or by the MMV identifier. M chimaera = Mycobacterium chimaera . M tuberculosis = Mycobacterium tuberculosis . M abscessus = Mycobacterium abscessus . MMV=Medicines for Malaria Venture. MIC=minimum inhibitory concentration. RFU=relative fluorescence units. REMA=resazurin <t>microtitre</t> cell viability assay.
Resazurin Microtitre Cell Viability Assay Rema, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rema+assay/resazurin+microtitre+cell+viability+assay+rema/pmc09042791-93-3-15
Average 90 stars, based on 1 article reviews
resazurin microtitre cell viability assay rema - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
rema-kalenga wildlife sanctuary  (CHOWDHURY AND CO LUTON LIMITED)
90
CHOWDHURY AND CO LUTON LIMITED rema-kalenga wildlife sanctuary
Antimicrobial compound hits identified from screening the Pathogen Box against M chimaera A) Validation of the <t>REMA</t> screening approach for M chimaera , demonstrating an estimated Z factor of 0·87. 50 times rifampicin mean MIC (2·5 μg/mL; red diamond) was compared to 2% dimethyl sulfoxide drug-free media (yellow triangle) in the REMA assay. Data points from three independent experiments were pooled. (B) The 400 Pathogen Box compounds screened against M chimaera, M tuberculosis , and M abscessus at 20 μM with cell survival quantified by REMA. Any compound that inhibited growth by 70% or more were classed as a hit (green bar). Compounds have been classified by MMV as A for cryptosporidiosis; B for kinetoplastids; C for malaria; D for reference compounds; E for schistosomiasis; and F for tuberculosis. (C) Venn diagram describing the overlap in antimicrobial compound hits against M chimaera, M abscessus , and M tuberculosis . The compounds are detailed as a drug name or by the MMV identifier. M chimaera = Mycobacterium chimaera . M tuberculosis = Mycobacterium tuberculosis . M abscessus = Mycobacterium abscessus . MMV=Medicines for Malaria Venture. MIC=minimum inhibitory concentration. RFU=relative fluorescence units. REMA=resazurin <t>microtitre</t> cell viability assay.
Rema Kalenga Wildlife Sanctuary, supplied by CHOWDHURY AND CO LUTON LIMITED, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rema+assay/rema+kalenga+wildlife+sanctuary/pmc09170557-396-52-38
Average 90 stars, based on 1 article reviews
rema-kalenga wildlife sanctuary - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
rema dynamic  (DENTAURUM GmbH Co KG)
90
DENTAURUM GmbH Co KG rema dynamic
Antimicrobial compound hits identified from screening the Pathogen Box against M chimaera A) Validation of the <t>REMA</t> screening approach for M chimaera , demonstrating an estimated Z factor of 0·87. 50 times rifampicin mean MIC (2·5 μg/mL; red diamond) was compared to 2% dimethyl sulfoxide drug-free media (yellow triangle) in the REMA assay. Data points from three independent experiments were pooled. (B) The 400 Pathogen Box compounds screened against M chimaera, M tuberculosis , and M abscessus at 20 μM with cell survival quantified by REMA. Any compound that inhibited growth by 70% or more were classed as a hit (green bar). Compounds have been classified by MMV as A for cryptosporidiosis; B for kinetoplastids; C for malaria; D for reference compounds; E for schistosomiasis; and F for tuberculosis. (C) Venn diagram describing the overlap in antimicrobial compound hits against M chimaera, M abscessus , and M tuberculosis . The compounds are detailed as a drug name or by the MMV identifier. M chimaera = Mycobacterium chimaera . M tuberculosis = Mycobacterium tuberculosis . M abscessus = Mycobacterium abscessus . MMV=Medicines for Malaria Venture. MIC=minimum inhibitory concentration. RFU=relative fluorescence units. REMA=resazurin <t>microtitre</t> cell viability assay.
Rema Dynamic, supplied by DENTAURUM GmbH Co KG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rema+assay/rema+dynamic/10__2298_slash_jsc100406014j-30-4-6
Average 90 stars, based on 1 article reviews
rema dynamic - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
rema dynamic s  (DENTAURUM GmbH Co KG)
90
DENTAURUM GmbH Co KG rema dynamic s
Antimicrobial compound hits identified from screening the Pathogen Box against M chimaera A) Validation of the <t>REMA</t> screening approach for M chimaera , demonstrating an estimated Z factor of 0·87. 50 times rifampicin mean MIC (2·5 μg/mL; red diamond) was compared to 2% dimethyl sulfoxide drug-free media (yellow triangle) in the REMA assay. Data points from three independent experiments were pooled. (B) The 400 Pathogen Box compounds screened against M chimaera, M tuberculosis , and M abscessus at 20 μM with cell survival quantified by REMA. Any compound that inhibited growth by 70% or more were classed as a hit (green bar). Compounds have been classified by MMV as A for cryptosporidiosis; B for kinetoplastids; C for malaria; D for reference compounds; E for schistosomiasis; and F for tuberculosis. (C) Venn diagram describing the overlap in antimicrobial compound hits against M chimaera, M abscessus , and M tuberculosis . The compounds are detailed as a drug name or by the MMV identifier. M chimaera = Mycobacterium chimaera . M tuberculosis = Mycobacterium tuberculosis . M abscessus = Mycobacterium abscessus . MMV=Medicines for Malaria Venture. MIC=minimum inhibitory concentration. RFU=relative fluorescence units. REMA=resazurin <t>microtitre</t> cell viability assay.
Rema Dynamic S, supplied by DENTAURUM GmbH Co KG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rema+assay/rema+dynamic+s/10__2186_slash_jpr__jpr_d_20_00321-40-13-16
Average 90 stars, based on 1 article reviews
rema dynamic s - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
rema method  (MiddleBrook Pharmaceuticals)
90
MiddleBrook Pharmaceuticals rema method
Antimicrobial compound hits identified from screening the Pathogen Box against M chimaera A) Validation of the <t>REMA</t> screening approach for M chimaera , demonstrating an estimated Z factor of 0·87. 50 times rifampicin mean MIC (2·5 μg/mL; red diamond) was compared to 2% dimethyl sulfoxide drug-free media (yellow triangle) in the REMA assay. Data points from three independent experiments were pooled. (B) The 400 Pathogen Box compounds screened against M chimaera, M tuberculosis , and M abscessus at 20 μM with cell survival quantified by REMA. Any compound that inhibited growth by 70% or more were classed as a hit (green bar). Compounds have been classified by MMV as A for cryptosporidiosis; B for kinetoplastids; C for malaria; D for reference compounds; E for schistosomiasis; and F for tuberculosis. (C) Venn diagram describing the overlap in antimicrobial compound hits against M chimaera, M abscessus , and M tuberculosis . The compounds are detailed as a drug name or by the MMV identifier. M chimaera = Mycobacterium chimaera . M tuberculosis = Mycobacterium tuberculosis . M abscessus = Mycobacterium abscessus . MMV=Medicines for Malaria Venture. MIC=minimum inhibitory concentration. RFU=relative fluorescence units. REMA=resazurin <t>microtitre</t> cell viability assay.
Rema Method, supplied by MiddleBrook Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rema+assay/rema+method/pm25203970-173-12-6
Average 90 stars, based on 1 article reviews
rema method - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
rema form  (DENTAURUM GmbH Co KG)
90
DENTAURUM GmbH Co KG rema form
Antimicrobial compound hits identified from screening the Pathogen Box against M chimaera A) Validation of the <t>REMA</t> screening approach for M chimaera , demonstrating an estimated Z factor of 0·87. 50 times rifampicin mean MIC (2·5 μg/mL; red diamond) was compared to 2% dimethyl sulfoxide drug-free media (yellow triangle) in the REMA assay. Data points from three independent experiments were pooled. (B) The 400 Pathogen Box compounds screened against M chimaera, M tuberculosis , and M abscessus at 20 μM with cell survival quantified by REMA. Any compound that inhibited growth by 70% or more were classed as a hit (green bar). Compounds have been classified by MMV as A for cryptosporidiosis; B for kinetoplastids; C for malaria; D for reference compounds; E for schistosomiasis; and F for tuberculosis. (C) Venn diagram describing the overlap in antimicrobial compound hits against M chimaera, M abscessus , and M tuberculosis . The compounds are detailed as a drug name or by the MMV identifier. M chimaera = Mycobacterium chimaera . M tuberculosis = Mycobacterium tuberculosis . M abscessus = Mycobacterium abscessus . MMV=Medicines for Malaria Venture. MIC=minimum inhibitory concentration. RFU=relative fluorescence units. REMA=resazurin <t>microtitre</t> cell viability assay.
Rema Form, supplied by DENTAURUM GmbH Co KG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rema+assay/rema+form/pm15211296-49-21-26
Average 90 stars, based on 1 article reviews
rema form - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Antimicrobial compound hits identified from screening the Pathogen Box against M chimaera A) Validation of the REMA screening approach for M chimaera , demonstrating an estimated Z factor of 0·87. 50 times rifampicin mean MIC (2·5 μg/mL; red diamond) was compared to 2% dimethyl sulfoxide drug-free media (yellow triangle) in the REMA assay. Data points from three independent experiments were pooled. (B) The 400 Pathogen Box compounds screened against M chimaera, M tuberculosis , and M abscessus at 20 μM with cell survival quantified by REMA. Any compound that inhibited growth by 70% or more were classed as a hit (green bar). Compounds have been classified by MMV as A for cryptosporidiosis; B for kinetoplastids; C for malaria; D for reference compounds; E for schistosomiasis; and F for tuberculosis. (C) Venn diagram describing the overlap in antimicrobial compound hits against M chimaera, M abscessus , and M tuberculosis . The compounds are detailed as a drug name or by the MMV identifier. M chimaera = Mycobacterium chimaera . M tuberculosis = Mycobacterium tuberculosis . M abscessus = Mycobacterium abscessus . MMV=Medicines for Malaria Venture. MIC=minimum inhibitory concentration. RFU=relative fluorescence units. REMA=resazurin microtitre cell viability assay.

Journal: The Lancet. Microbe

Article Title: Searching for new therapeutic options for the uncommon pathogen Mycobacterium chimaera : an open drug discovery approach

doi: 10.1016/S2666-5247(21)00326-8

Figure Lengend Snippet: Antimicrobial compound hits identified from screening the Pathogen Box against M chimaera A) Validation of the REMA screening approach for M chimaera , demonstrating an estimated Z factor of 0·87. 50 times rifampicin mean MIC (2·5 μg/mL; red diamond) was compared to 2% dimethyl sulfoxide drug-free media (yellow triangle) in the REMA assay. Data points from three independent experiments were pooled. (B) The 400 Pathogen Box compounds screened against M chimaera, M tuberculosis , and M abscessus at 20 μM with cell survival quantified by REMA. Any compound that inhibited growth by 70% or more were classed as a hit (green bar). Compounds have been classified by MMV as A for cryptosporidiosis; B for kinetoplastids; C for malaria; D for reference compounds; E for schistosomiasis; and F for tuberculosis. (C) Venn diagram describing the overlap in antimicrobial compound hits against M chimaera, M abscessus , and M tuberculosis . The compounds are detailed as a drug name or by the MMV identifier. M chimaera = Mycobacterium chimaera . M tuberculosis = Mycobacterium tuberculosis . M abscessus = Mycobacterium abscessus . MMV=Medicines for Malaria Venture. MIC=minimum inhibitory concentration. RFU=relative fluorescence units. REMA=resazurin microtitre cell viability assay.

Article Snippet: We validated the resazurin microtitre cell viability assay (REMA) as a screening method, REMA (CellTiter-Blue, Promega, Madison, WI, USA) was used to determine the antimicrobial activities of the drugs.

Techniques: Biomarker Discovery, Concentration Assay, Fluorescence, Viability Assay